Treatment of atypical leishmaniasis with interferon ? resulting in progression of Kaposi's sarcoma in an AIDS patient
- 1 December 1994
- journal article
- case report
- Published by Springer Nature in Journal of Molecular Medicine
- Vol. 72 (12) , 1041-1047
- https://doi.org/10.1007/bf00577752
Abstract
Visceral leishmaniasis (kala-azar) affecting HIV-infected patient is being reported in increasing frequency. A 40-year-old German bisexual patient with full-blown AIDS is described who presented with Kaposi's sarcoma, epigastric pain, diarrhea, and weight loss but without fever.Leishmania amastigotes were initially found in biopsies from stomach, duodenum, and a cutaneous Kaposi's sarcoma lesion but were later also recovered from bone marrow and lymph node. The patient received three courses of a combination of pentavalent antimony and interferon-γ. In addition to the common side effects such as fever, thrombocytopenia, and elevated amylase and lipase, a vivid progression of the Kaposi's sarcoma was noted. Tumor progression was temporally closely associated with treatment with interferon-γ. Because this phenomemon has also been observed in other patients, we advise caution when using interferon-γ in patients with Kaposi's sarcoma.Keywords
This publication has 41 references indexed in Scilit:
- Visceral leishmaniasis in an HIV-infected patient: Clinical features and response to treatmentJournal of Molecular Medicine, 1991
- Progression of Kaposi's Sarcoma under a combined interferon beta and interferon gamma therapy in AIDS patientsJournal of Molecular Medicine, 1990
- Treatment of Visceral Leishmaniasis with Pentavalent Antimony and Interferon GammaNew England Journal of Medicine, 1990
- Immunotherapy for Parasitic DiseaseNew England Journal of Medicine, 1990
- A phase I trial of recombinant human interferon-γ in patients with Kaposi's sarcoma and the acquired immunodeficiency syndrome (AIDS)Journal of Clinical Immunology, 1989
- Short communication Visceral leishmaniasis (kala azar) in a patient with AIDSAIDS, 1989
- Immunochemotherapy for Intracellular Leishmania donovani Infection: Interferon Plus Pentavalent AntimonyThe Journal of Infectious Diseases, 1988
- Viszerale Leishmaniose (Kala-Azar) bei erworbenem Immundefektsyndrom (AIDS)Deutsche Medizinische Wochenschrift (1946), 1988
- Absence of gamma interferon and interleukin 2 production during active visceral leishmaniasis.Journal of Clinical Investigation, 1985
- Killing of intracellular Leishmania donovani by lymphokine-stimulated human mononuclear phagocytes. Evidence that interferon-gamma is the activating lymphokine.Journal of Clinical Investigation, 1983